title: A novel implementation of mARC treatment for non-dedicated planning systems using converted IMRT plans.
abstract: BACKGROUND
  The modulated arc (mARC) technique has recently been introduced by Siemens as an analogue to VMAT treatment. However, up to now only one certified treatment planning system supports mARC planning. We therefore present a conversion algorithm capable of converting IMRT plans created by any treatment planning system into mARC plans, with the hope of expanding the availability of mARC to a larger range of clinical users and researchers. As additional advantages, our implementation offers improved functionality for planning hybrid arcs and provides an equivalent step-and-shoot plan for each mARC plan, which can be used as a back-up concept in institutions where only one linac is equipped with mARC.
  
  
  METHODS
  We present a feasibility study to outline a practical implementation of mARC plan conversion using Philips Pinnacle and Prowess Panther. We present examples for three different kinds of prostate and head-and-neck plans, for 6 MV and flattening-filter-free (FFF) 7 MV photon energies, which are dosimetrically verified.
  
  
  RESULTS
  It is generally more difficult to create good quality IMRT plans in Pinnacle using a large number of beams and few segments. We present different ways of optimization as examples. By careful choosing the beam and segment arrangement and inversion objectives, we achieve plan qualities similar to our usual IMRT plans. The conversion of the plans to mARC format yields functional plans, which can be irradiated without incidences. Absolute dosimetric verification of both the step-and-shoot and mARC plans by point dose measurements showed deviations below 5% local dose, mARC plans deviated from step-and-shoot plans by no more than 1%. The agreement between GafChromic film measurements of planar dose before and after mARC conversion is excellent. The comparison of the 3D dose distribution measured by PTW Octavius 729 2D-Array with the step-and-shoot plans and with the TPS is well above the pass criteria of 90% of the points falling within 5% local dose and 3 mm distance to agreement. For all plans, the treatment time was noticeably reduced by conversion to mARC.
  
  
  CONCLUSIONS
  We present the feasibility test for converting IMRT step-and-shoot plans from the RTP-output of any treatment planning system (Philips Pinnacle and Prowess Panther, in our case) into mARC plans. The feasibility and dosimetric equivalence is demonstrated for the examples of a prostate and a head-and-neck patient.
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Dzierma
authors.forename: Frank
authors.initials: F
authors.lastname: Nuesken
authors.forename: Norbert
authors.initials: N
authors.lastname: Licht
authors.forename: Christian
authors.initials: C
authors.lastname: Ruebe
mesh_terms: D005240:Feasibility Studies; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods*
references.citation: Med Phys. 2011 Sep;38(9):5104-18
references.pmid: 21978056
references.citation: Med Phys. 2009 Jun;36(6):2328-39
references.pmid: 19610322
references.citation: Radiother Oncol. 2009 Jul;92(1):111-7
references.pmid: 19157609
references.citation: Radiother Oncol. 2011 Nov;101(2):298-302
references.pmid: 21907438
references.citation: Radiat Oncol. 2011 Dec 09;6:170
references.pmid: 22152490
references.citation: Med Phys. 2012 Feb;39(2):951-63
references.pmid: 22320804
references.citation: Med Phys. 2012 May;39(5):2595-602
references.pmid: 22559630
references.citation: Br J Radiol. 2011 Nov;84(1007):967-96
references.pmid: 22011829
references.citation: Med Phys. 2008 Jan;35(1):310-7
references.pmid: 18293586
references.citation: Phys Med Biol. 2011 Oct 7;56(19):6205-22
references.pmid: 21891848
references.citation: J Appl Clin Med Phys. 2012 Jul 05;13(4):3912
references.pmid: 22766955
references.citation: Phys Med Biol. 2011 Apr 7;56(7):1931-46
references.pmid: 21364260
references.citation: Radiother Oncol. 2009 Nov;93(2):259-65
references.pmid: 19748146